Successful treatment of post-pericardiotomy syndrome via C1 inhibitor replacement therapy in a hereditary angioedema patient with Marfan syndrome.

Topyildiz, Ezgi; Senol, Handan Duman; Gülen, Figen; Demir, Esen; Gökmen, Nihal Mete

Topyildiz, Ezgi; Senol, Handan Duman; Gülen, Figen; Demir, Esen; Gökmen, Nihal Mete.

Afiliação

Topyildiz E; Division of Pediatric Allergy and Clinical Immunology, Department of Pediatrics, Ege University Faculty of Medicine, Izmir.
Senol HD; Division of Pediatric Allergy and Clinical Immunology, Department of Pediatrics, Ege University Faculty of Medicine, Izmir.
Gülen F; Division of Pediatric Allergy and Clinical Immunology, Department of Pediatrics, Ege University Faculty of Medicine, Izmir.
Demir E; Division of Pediatric Allergy and Clinical Immunology, Department of Pediatrics, Ege University Faculty of Medicine, Izmir.
Gökmen NM; Division of Allergy and Clinical Immunology, Department of Internal Medicine Allergy, Ege University Faculty of Medicine, Izmir, Türkiye.

Turk J Pediatr ; 65(2): 338-343, 2023.

Article em En | MEDLINE | ID: mdl-37114700

Assuntos

Angioedemas Hereditários; Síndrome de Marfan; Masculino; Humanos; Criança; Proteína Inibidora do Complemento C1/uso terapêutico; Proteína Inibidora do Complemento C1/genética; Angioedemas Hereditários/complicações; Angioedemas Hereditários/tratamento farmacológico; Angioedemas Hereditários/prevenção & controle; Síndrome de Marfan/complicações; Síndrome de Marfan/tratamento farmacológico; Pericardiectomia; Coração

Palavras-chave

C1 inhibitor replacement therapy; Marfan syndrome; hereditary angioedema; post-pericardiotomy syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Angioedemas Hereditários / Síndrome de Marfan Limite: Child / Humans / Male Idioma: En Revista: Turk J Pediatr Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google